AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Three-Year Follow-Up On Safety And Effectiveness Of Rituximab Plus Chemotherapy As First-Line Treatment Of Diffuse Large B-Cell Lymphoma

Jifeng Feng,Jianqiu Wu,Yongping Song,Liping Su,Mingzhi Zhang,Wei Li,Yu Hu,Xiaohong Zhang,Yuhuan Gao,Zuoxing Niu,Ru Feng,Wei Wang,Jiewen Peng,Xiaolin Li,Xuenong Ouyang,Changping Wu,Weijing Zhang,Yun Zeng,Zhen Xiao,Yingmin Liang,Yongzhi Zhuang,Jishi Wang,Zimin Sun,Hai Bai,Tongjian Cui

BLOOD（2017）

引用 0|浏览49
暂无评分
摘要
Background:
更多
查看译文
关键词
rituximab,chemotherapy,three-year,first-line,b-cell
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要